Sd. Donevan et Rt. Mccabe, Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors, MOLEC PHARM, 58(3), 2000, pp. 614-623
Conantokin G (Con G) is a 17-amino-acid peptide antagonist of N-methyl-D-as
partate (NMDA) receptors isolated from the venom of the marine cone snail,
Conus geographus. The mechanism of action of Con G has not been well define
d; both competitive and noncompetitive interactions with the NMDA-binding s
ite have been proposed. In this study the mechanism of action and subunit s
electivity of Con G was examined in whole-cell voltage-clamp recordings fro
m cultured neurons and in two electrode voltage-clamp recordings from Xenop
us oocytes expressing recombinant NMDA receptors. Con G was a potent and se
lective antagonist of NMDA-evoked currents in murine cortical neurons (IC50
= 480 nM). The slow onset of Con G block could be prevented by coapplicati
on with high concentrations of NMDA or of the competitive antagonist (RS)-3
-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid. Furthermore, in oocyt
es expressing NR1a/NR2B receptors, Con G produced a rightward shift in the
concentration-response curve for NMDA, providing support for a competitive
interaction with the NMDA-binding site. Con G produced an apparent noncompe
titive shift in the concentration-response curve for spermine potentiation
of NMDA responses, but this was due to spermine-induced enhancement of Con
G block. Spermine produced a similar enhancement of DL-2-amino-S-phosphopen
tanoic acid block. Finally, Con G selectively blocked NMDA receptors contai
ning the NR2B subunit. These results demonstrate that Con G is a subunit-sp
ecific competitive antagonist of NMDA receptors. The unique subunit selecti
vity profile of Con G may explain its favorable in vivo profile compared wi
th nonselective NMDA antagonists.